advertising
Link to jump to start of content The Seattle Times Company Jobs Autos Homes Rentals NWsource Classifieds seattletimes.com
The Seattle Times Business & Technology
Traffic | Weather | Your account Movies | Restaurants | Today's events

News, analysis and perspectives from the
technology team at The Seattle Times.
Have a news tip? Follow the links below to e-mail us.

All blogs and discussions:

Go

February 15, 2006

Richland's IsoRay starts year with cash

Posted by Benjamin J. Romano at 2:30 PM

The Richland company that makes radioactive "seeds" that can be inserted into solid tumors to treat cancer is touting a banner start to the year.

IsoRay Medical said it closed a $6 million private funding round at the end of January and has since raised more than $1.3 million through a new placement opened Feb. 1 to accommodate excess demand from investors.

It also signed a licensing agreement with a Belgian company that IsoRay says will reduce manufacturing and production costs of Cesium-131, the radioactive isotope it makes to treat prostate cancer. The collaborator, International Brachytherapy, can produce polymer seeds, which IsoRay CEO Roger Girard said offer advantages over the titanium seeds his company currently manufactures.

Share:    Digg     Newsvine

Tricia Duryee
Tricia Duryee
E-mail|Bio


Angel Gonzalez
Angel Gonzalez
E-mail|Bio


Kristi Heim
Kristi Heim
E-mail|Bio


Benjamin J. Romano
Benjamin J. Romano
E-mail|Bio


Mark Watanabe
Mark
Watanabe

E-mail|Bio

Marketplace

advertising

advertising